Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2
Diabetes. Both the safety and blood sugar lowering effects of these treatments will be
studied.